Crinetics Pharmaceuticals, Inc. (CRNX) is listed on NASDAQ in Pharmaceutical Stocks. It is $84.85, +0.00%, with a $9.0B market cap. RSI is 71.8, overbought. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 71.8 Overbought
Market Cap $9.0B
Volume 631.1K
Fundamentals — 10-Q Q2 2026
Revenue $35.9M
Net Income $-248.7M
EPS $-2.37
Gross Margin 99.0%
Operating Margin -761.0%
Net Margin -693.7%
P/E Ratio -35.8x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Vivaldi Coelho Rogerio | Director | Sell | 3,000 | $40.00 | $120,000 | 2026 Jul 2 |
| Okey Stephanie | Director | Sell | 6,900 | $35.67 | $246,143 | 2026 Jun 17 |
| Knight Jeff E. | Chief Dev. & Operating Officer | Sell | 85,163 | $40.10 | $3.4M | 2026 Apr 8 |
| Vivaldi Coelho Rogerio | Director | Sell | 5,000 | $36.15 | $180,761 | 2026 Mar 12 |
| Okey Stephanie | Director | Sell | 3,000 | $39.67 | $119,010 | 2026 Mar 3 |
| Schilke Tobin | Chief Financial Officer | Sell | 6,713 | $39.67 | $266,305 | 2026 Mar 3 |
| Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $45.02 | $225,100 | 2025 Dec 1 |
| Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $42.66 | $213,312 | 2025 Nov 3 |
| Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $41.81 | $209,050 | 2025 Oct 1 |
| Struthers Richard Scott | President & CEO | Sell | 4,000 | $45.00 | $180,000 | 2025 Sep 26 |
| Fust Matthew K | Director | Sell | 16,000 | $44.75 | $716,000 | 2025 Sep 26 |
| Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $32.10 | $160,500 | 2025 Sep 2 |
| Pizzuti Dana | Chief Med and Dev Officer | Sell | 30,000 | $30.43 | $912,900 | 2025 Aug 22 |
| Pizzuti Dana | Chief Med and Dev Officer | Sell | 6,492 | $29.18 | $189,437 | 2025 Aug 20 |
| Betz Stephen F. | Chief Scientific Officer | Sell | 97,483 | $32.23 | $3.1M | 2025 Jun 12 |
| Knight Jeff E. | Chief Operating Officer | Sell | 7,162 | $34.20 | $244,964 | 2025 Mar 19 |
| Struthers Richard Scott | President & CEO | Sell | 17,338 | $34.20 | $593,017 | 2025 Mar 19 |
| Betz Stephen F. | Chief Scientific Officer | Sell | 5,770 | $34.20 | $197,353 | 2025 Mar 19 |
| Pizzuti Dana | Chief Med and Dev Officer | Sell | 2,515 | $34.20 | $86,021 | 2025 Mar 19 |
| Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $39.07 | $195,350 | 2025 Feb 3 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $345.04 | 48.5 | $9.6B |
| | $34.17 | 49.9 | $2.5B |
| | $24.11 | 48.8 | $12.0B |
| | $366.76 | 62.3 | $542.1B |
Take CRNX further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put CRNX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Crinetics Pharmaceuticals, Inc. next reports.
Set alerts on CRNX
Get notified when Crinetics Pharmaceuticals, Inc. hits your price targets or technical conditions are met.
Get Started Free